Based on the increased expression of BRD9 and the importance of bromodomain-containing proteins in thyroid tumor development, tumor growth, and progression, we tested the efficacy of a specific inhibitor of these three proteins (GSK2801) [25]. Here, BRD9 is linked to neoplasm.